Recombinant Mouse NTPDase 2/ENTPD2 Protein (His Tag) | PKSM041340

(No reviews yet) Write a Review
SKU:
575-PKSM041340
€641.00
Frequently bought together:

Description

Recombinant Mouse NTPDase 2/ENTPD2 Protein (His Tag) | PKSM041340 | Gentaur US, UK & Europe Disrtribition

Synonyms: Ectonucleoside triphosphate diphosphohydrolase 2; Entpd2; Ecto-Nucleoside Triphosphate Diphosphohydrolase 2

Active Protein: N/A

Activity: Recombinant Mouse ENTPD2 is produced by our Mammalian expression system and the target gene encoding Cys26-Ser462 is expressed with a 6His tag at the C-terminus.

Protein Construction: Recombinant Mouse ENTPD2 is produced by our Mammalian expression system and the target gene encoding Cys26-Ser462 is expressed with a 6His tag at the C-terminus.

Fusion Tag: C-His

Species: Mouse

Expressed Host: Human Cells

Shipping: This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at<-20°C.

Purity: > 95 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per μg as determined by the LAL method.

Stability and Storage: Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.

Molecular Mass: 49.2 kDa

Formulation: Supplied as a 0.2 μm filtered solution of 50mM Tris, 10mM CaCl2, 150mMNaCl, 10%Glycerol, pH7.5 .

Reconstitution: Not Applicable

Background: CD39L1 protein (ENTPD2 or NTPDase2) is a member of the ecto-nucleoside triphosphate diphosphohydrolase family which the main role is termination of purinergic signaling. CD39L1 gene encodes a precursor protein with 495 amino acid residues which generates a 437 amino acid residues mature protein after processing. It is an ecto-nucleotidase that found on the surface of vascular adventitial cells and accessory vascular cells. CD39L1 is a Ca2+- and Mg2+-dependent enzyme that activates platelets by preferentially converting ATP to ADP. CD39L1 plays a role in regulating thrombosis and inflammation which is considered to be a therapeutic target for thromboregulation and the treatment of vascular inflammation. Alternative splicing of CD39L1 gene results in multiple transcript variants.

Research Area: N/A

View AllClose